TENTATIVE PROGRAM
Kindly note that Programme is tentative and may subject to changes
| 2025-09-17 | 2025-09-18 | 2025-09-19 | 2025-09-20 | ||||||||||||||||
| 13:30 15:00 | 15:15 16:45 | 08:00 08:15 | 08:15 10:15 | 10:30 11:15 | 11:15 12:15 | 13:00 14:30 | 14:30 15:30 | 15:45 17:15 | 17:15 18:15 | 08:00 10:00 | 10:30 11:15 | 11:15 12:15 | 13:00 14:30 | 14:30 15:30 | 15:45 17:15 | 08:30 10:00 | 10:35 11:15 | 11:15 12:00 | |
| ROOM 1 | Committee Meeting | Committee Meeting | Opening Remarks | Presidential Symposium Defining standards and accreditation of HSCT center | Plenary Session 1 Evolution on Conditioning | Sponsored Symposium | Session 1 Donor Selection/ Alternative Donor SCT | Sponsored Symposium | Session 4 HSCT Complication - Infection | Poster Session | Session 7 CAR-T Cell Therapy Laboratory aspect | Plenary Session 2 Evolution on GVHD prophylaxis | Sponsored Symposium | Oral Presentation | Sponsored Symposium | Session 9 Leukemia, MDS, MPN | Session 11 Lymphoma/Myeloma | Plenary Session 3 Artificial Intelligent in HSCT | Award Announcements and Closing Remarks |
| ROOM 2 | Session Haplo-HSCT | Session 5 CAR-T Cell Therapy Clinical aspect | Session Pediatric HSCT (malignancy) | Session 10 Pediatric HSCT (non-malignancy) | Session 12 Enhancing Access to HSCT: Establishing services with limited resources | Plenary Session 3 Artificial Intelligent in HSCT | |||||||||||||
| ROOM 3 | Session 3 HSCT Complication - GVHD | Session 6 Conditioning Regimen | Multidisciplinary Session 1 Laboratory | Multidisciplinary Session 2 Quality Management/FACT-JACIE/Analyzing and reporting outcomes | Multidisciplinary Session 3 Patient advocacy | Session 13 Long-term follow-up | |||||||||||||
| VIP 3-4 | Committee Meeting/ Education Session | Committee Meeting/ Education Session | Nurse Session 1 General HSCT nursing care | Nurse Session 2 Long-term follow -up care | Nurse Session 3 CAR-T cell therapy | Nurse Oral Presentation | |||||||||||||